GlassScriptPhysician profile
Jason Meade Weber
NPI 1063574515
$1,366.88
in general payments reported to CMS, 2019-2025
20 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $111 · 2021: $298 · 2022: $159 · 2023: $319 · 2024: $48.65 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $218.93 | 2019-2023 | Puraply |
| Horizon Therapeutics Plc | $195.13 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $132.52 | 2023-2025 | Esprit, Eterna |
| Smith+Nephew, INC. | $127.43 | 2020-2023 | Grafix Pl, Renasys Go V2 Home, Pico 7 |
| Bioventus LLC | $124.99 | 2022 | |
| Melinta Therapeutics, LLC | $124.97 | 2019 | |
| Kerecis Limited | $112.10 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Alfasigma USA, INC. | $42.71 | 2021-2022 | |
| Wright Medical Technology, INC. | $31.01 | 2020 | |
| Innovation Technologies INC | $29.54 | 2021 | |
| Medtronic, INC. | $22.65 | 2023 | Intellis Adaptivestim |
| Triad Life Sciences INC. | $22.17 | 2022 | |
| Baudax Bio INC. | $20.11 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.96 | 2023 | Nuzyra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $16.25 | 2023 | Senza |
| Sebela Pharmaceuticals INC. | $14.06 | 2023 | Naftin |
| Arthrosurface Incorporated | $13.81 | 2019 | |
| Merck Sharp & Dohme LLC | $11.41 | 2019 | |
| Tactile Systems Technology INC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.